KPTI · Forms 3, 4, 5
Insider trades at Karyopharm Therapeutics Inc.
1 insider sold $450 of Karyopharm Therapeutics Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Karyopharm Therapeutics Inc. (KPTI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kristin Abate | Chief Accounting Officer | Sell | 378 | $1.19 | $450 | Form 4 | |
| Kristin Abate | Chief Accounting Officer | Sell | 19 | $2.02 | $38 | Form 4 | |
| Stuart Poulton | EVP, Chief Development Officer | Sell | 189 | $7.10 | $1K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.